scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020937977 |
P356 | DOI | 10.1038/SREP30026 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep30026 |
P932 | PMC publication ID | 4948019 |
P698 | PubMed publication ID | 27424772 |
P50 | author | Maartje J. Hooning | Q74014444 |
Antoinette Hollestelle | Q37074515 | ||
P2093 | author name string | J Margriet Collée | |
Jingjing Liu | |||
Marjanka K Schmidt | |||
John A Foekens | |||
Senno Verhoef | |||
John W M Martens | |||
Frans B L Hogervorst | |||
Sten Cornelissen | |||
Ans M W van den Ouweland | |||
Wendy J C Prager-van der Smissen | |||
Anja Nieuwlaat | |||
Roy Lamping | |||
P2860 | cites work | HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression | Q37668201 |
Discovering moderate-risk breast cancer susceptibility genes | Q37719902 | ||
The homeodomain protein HOXB13 regulates the cellular response to androgens | Q39773980 | ||
The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer | Q40058996 | ||
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis | Q41748948 | ||
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk | Q44440396 | ||
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk | Q44708071 | ||
G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis | Q45369342 | ||
Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls. | Q45903526 | ||
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. | Q46000370 | ||
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
Germline mutations in HOXB13 and prostate-cancer risk | Q28257179 | ||
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer | Q28266001 | ||
PON-P2: prediction method for fast and reliable identification of harmful variants | Q28543185 | ||
Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study | Q33274430 | ||
Breast-cancer risk in families with mutations in PALB2 | Q34148873 | ||
Collective judgment predicts disease-associated single nucleotide variants | Q34354991 | ||
HOX genes and their role in the development of human cancers. | Q34427951 | ||
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer | Q35097143 | ||
Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population | Q35477949 | ||
Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates | Q35827235 | ||
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer | Q36438352 | ||
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). | Q36503369 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease | Q36741627 | ||
The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial | Q36895390 | ||
PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations | Q37487954 | ||
Association of a HOXB13 variant with breast cancer | Q37588396 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 30026 | |
P577 | publication date | 2016-07-18 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk | |
P478 | volume | 6 |
Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk | cites work | P2860 |
Search more.